Preview

Journal Biomed

Advanced search

Experimental modeling of chronic warm insufficiency

Abstract

Introduction of new methods of treatment of chronic warm insufficiency demands the adequate evidential base including preclinical researches on experimental models at animals. Successful approbation of several experimental models of formation of warm insufficiency at the laboratory animals allowing by means of a method of an echocardiography to investigate various options of a course of a disease, both on expressiveness of hemodynamic manifestations, and on primary defeat of departments of heart is carried out. The most effective in terms of reproducibility and intensity of the changes is the model with a permanent ligation of the left coronary artery. Among the features of pharmacological models doxorubicin model of chronic heart failure is a progressive decrease in left ventricular contractility and the development of his eccentric remodeling, whereas izadrin model is characterized by the development of a moderate heart failure, and the introduction of monocrotaline is mainly the development of pulmonary hypertension, right ventricular hypertrophy and severe right heart failure.

About the Authors

A. A. Kazachenko
Военно-медицинская академия им. С.М. Кирова МО РФ, Санкт-Петербург
Russian Federation


S. V. Okovityy
Химико-фармацевтическая академия МЗ РФ, Санкт-Петербург
Russian Federation


A. N. Kulikov
Военно-медицинская академия им. С.М. Кирова МО РФ, Санкт-Петербург
Russian Federation


D. Yu. Ivkin
Химико-фармацевтическая академия МЗ РФ, Санкт-Петербург
Russian Federation


E. B. Shustov
ФГБУН «Научный центр биомедицинских технологий ФМБА России», Московская обл
Russian Federation


References

1. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. – М.: Ремедиум. 2005. 829 с.

2. Christiansen S., Redmann K., Scheld H.H., et al. Adriamycin-induced cardiomyopathy in the dog – an appropriate model for research on partial left ventriculectomy // J. Heart Lung Transplant. 2002. Vol. 21. № 7. Р. 783-790.

3. Elsner D., Riegger G.A.J. Characteristics and clinical relevance of animal models of heart failure /D. Elsner // Curr Opinion Cardiol. 1995. Vol. 10. № 3. Р. 253-259.

4. Gram T.E. Metabolic activation and toxicity of chemical agents to lung tissue and cells / Pergamon Press, Oxford. 1993. Р. 239-254.

5. Lee V., Randhawa A.K., Singal P.K. Adriamycin-induced myocardialdysfunction in vitro is mediated by free radicals // Am J. Physiol. 1991. Vol. 261. № 4. Pt. 4. Р. 989-995. А.А. Казаченко, С.В. Оковитый, А.Н. Куликов, Д.Ю. Ивкин, Е.Б. Шустов

6. Monnet E., Orton E.C. A canine 9. Weinberg L.E., Singal P.K. Refractorymodel of heart failure by intracoronary heart failure and age-related differences adriamycin injection: hemodynamic in adriamycin-induced myocardialand energetic results // J. Card. Fail. changes in rats // Can J. Physiol. 1999. Vol. 5. № 3. Р. 255-264. Pharmacol. 1987. Vol. 65. № 9. Р.

7. Robinovitch M. Investigational 1957-1965. approaches to pulmonary hypertension 10. Wilson D.W., Segall H.J., Pan L.C., // Toxicol. Pathol. 1991. Vol. 19. № 4. et al. Mechanisms and pathology of Pt. 1. Р. 458-469. monocrotaline toxicity // Crit. Rev.

8. Toyoda Y., Okada M., Kashem A.M.Toxicol. 1992. Vol. 22, № 5. Р. 307-325. A canine model of dilated cardiomyopathy induced byrepetitive intracoronary doxorubicin administration // J. Thorac. Cardiovasc. Surg. 1998. Vol. 115. № 6. Р. 13671373.


Review

For citations:


Kazachenko A.A., Okovityy S.V., Kulikov A.N., Ivkin D.Yu., Shustov E.B. Experimental modeling of chronic warm insufficiency. Journal Biomed. 2013;1(3):41-48. (In Russ.)

Views: 537


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)